BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
CAPS Rating:
A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.
RSS Headlines
Fool UK
Recs
Zacks Rank 3-Hold, Recommend Neutral, Industry Rank 75 / 265, Target 4.90, Avg target of 3 analysts 7.67
- set limit lid @ 4.12 (+.10)